REGULATORY INSPECTIONS definition

REGULATORY INSPECTIONS means an inspection by any Regulatory Authority of the Facility or of Chesapeake's processes and/or equipment used in Manufacture or in the storage of Finished Products, or any part or component thereof;

Examples of REGULATORY INSPECTIONS in a sentence

  • AND NON-CONFORMANCE 10 Article 12 REFERENCE AND RETENTION SAMPLES 12 Article 13 STORAGE OF PRODUCT / ENVIRONMENTAL MONITORING 12 Article 14 COMPLAINTS 13 Article 15 CHANGE CONTROL 13 Article 16 REPROCESSING AND REWORK 14 Article 17 SUB-CONTRACTING 14 Article 18 REGULATORY INSPECTIONS 14 Article 19 PERIODIC QUALITY REVIEWS 15 Article 20 ON-GOING GMP STABILITY 15 Article 21 ANNUAL REPORT 15 * Confidential treatment requested.

  • MONITORING/AUDITS/REGULATORY INSPECTIONS 56 13.1 MONITORING 56 13.2 AUDITS 56 13.3 REGULATORY INSPECTIONS 56 14.

  • JOHSC FORMAL RECOMMENDATION LETTERS & REGULATORY INSPECTIONS (e.g., WorkSafeBC) competing priorities and may not physically be capable of shovelling snow.Gerald will aim to reach out to all JOHSC co-chairs at UBC and determine if there is interest in sending a joint formal recommendation letter to the employer.

  • JOHSC FORMAL RECOMMENDATION LETTERS & REGULATORY INSPECTIONS (e.g., WorkSafeBC) Overall accessibility pathways are still not being cleared.

  • Noble Lewis Dugger 5/2007 64-65 Noble Gene Rosser 10/2006 66-68 ANTICIPATE +/- 10 DAYS OF DOWNTIME BEGINNING JUNE 28 FOR REGULATORY INSPECTIONS.

Related to REGULATORY INSPECTIONS

  • Regulatory Information Service means a regulatory information service as defined in the Takeover Rules.

  • Lead inspection means a surface-by-surface investigation to determine the presence of lead-based

  • Studies means activities needed to prepare project implementation, such as preparatory, mapping, feasibility, evaluation, testing and validation studies, including in the form of software, and any other technical support measure, including prior action to define and develop a project and decide on its financing, such as reconnaissance of the sites concerned and preparation of the financial package;

  • Inspections has the meaning set forth in Section 4.1.2.

  • Clinical Studies means human clinical trials for a Licensed Product and any other tests and studies for a Licensed Product in human subjects.

  • Explanatory Indicator means a measure that is connected to and helps to explain performance in a Performance Indicator or a Monitoring Indicator. An Explanatory Indicator may or may not be a measure of the HSP’s performance. No Performance Target is set for an Explanatory Indicator;

  • External inspection means an inspection made when a boiler is in operation.

  • Regulatory Agencies The Office of the Comptroller of the Currency; the Board of Governors of the Federal Reserve System; the Federal Deposit Insurance Corporation; the Federal Housing Finance Agency; the Securities and Exchange Commission; and the Department of Housing and Urban Development.

  • Adverse Event means any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and that does not necessarily have a causal relationship with the treatment. An adverse event can therefore be any unfavourable and unintended sign (including an abnormal laboratory finding), symptom, or disease temporally associated with the use of a medicinal product, whether or not related to the medicinal product.

  • Regulatory Bodies means those government departments and regulatory, statutory and other entities, committees, ombudsmen and bodies which, whether under statute, rules, regulations, codes of practice or otherwise, are entitled to regulate, investigate, or influence the matters dealt with in the Contract or any other affairs of the Authority and “Regulatory Body” shall be construed accordingly.

  • Public Procurement Regulatory Authority (PPRA) means the Government Agency responsible for oversight of public procurement.

  • Updates are changes that do not require a change to the established Centralized Contract terms and conditions. A request to add new products at the same or better price level is an example of an update. “Amendments” are any changes that are not specifically covered by the terms and conditions of the Centralized Contract, but inclusion is found to be in the best interest of the State. A request to change a contractual term and condition is an example of an amendment.

  • Regulatory Materials means regulatory applications, submissions, notifications, registrations, Marketing Authorizations or other written materials, correspondence, submissions made to or with a Regulatory Authority that are necessary or reasonably desirable in order to Develop, Manufacture or Commercialize the Licensed Products in the Field in a particular country.

  • contracting authorities means the State, regional or local authorities, bodies governed by public law or associations formed by one or more such authorities or one or more such bodies governed by public law;

  • Study means the investigation to be conducted in accordance with the Protocol.

  • Regulatory Data means any and all research data, pharmacology data, chemistry, manufacturing, and control data, preclinical data, clinical data or all other documentation submitted, or required to be submitted, to Regulatory Authorities in association with regulatory filings for the Product in the Field (including any Drug Master Files (DMFs), Chemistry, Manufacturing and Control (“CMC”) data, or similar documentation).

  • Regulatory Authorities means the Commissions and the Exchange;

  • Protocols means written directions and orders, consistent with the department’s standard of care, that are to be followed by an emergency medical care provider in emergency and nonemergency situations. Protocols must be approved by the service program’s medical director and address the care of both adult and pediatric patients.

  • Facilities Study shall be an engineering study conducted by the Transmission Provider (in coordination with the affected Transmission Owner(s)) to: (1) determine the required modifications to the Transmission Provider’s Transmission System necessary to implement the conclusions of the System Impact Study; and (2) complete any additional studies or analyses documented in the System Impact Study or required by PJM Manuals, and determine the required modifications to the Transmission Provider’s Transmission System based on the conclusions of such additional studies. The Facilities Study shall include the cost and scheduled completion date for such modifications, that will be required to provide the requested transmission service or to accommodate a New Service Request. As used in the Interconnection Service Agreement or Construction Service Agreement, Facilities Study shall mean that certain Facilities Study conducted by Transmission Provider (or at its direction) to determine the design and specification of the Customer Funded Upgrades necessary to accommodate the New Service Customer’s New Service Request in accordance with Tariff, Part VI, section 207.

  • Final Inspection means the process and procedure described in UGC Section 12.

  • Benchmarking Information means information generated by Portfolio Manager, as herein defined including descriptive information about the physical building and its operational characteristics.

  • Study Data shall have the meaning set forth in Section 8.1.

  • competent authorities means the competent authorities of the Member States as identified on the websites listed in Annex II;

  • Clinical means having a significant relationship, whether real or potential, direct or indirect, to the actual rendering or outcome of dental care, the practice of dentistry, or the quality of dental care being rendered to a patient;

  • Home inspection means the on-site, physical review of the home of an applicant to assure the applicant and the home meets all health and safety requirements within these rules.

  • Regulatory Services Provider means the organization which provides regulatory services to BSEF pursuant to a Regulatory Services Agreement.